转甲状腺素
四聚体
化学
淀粉样多发性神经病
异喹啉
淀粉样变性
单体
淀粉样蛋白(真菌学)
淀粉样纤维
立体化学
生物化学
医学
内科学
酶
淀粉样β
有机化学
疾病
发病年龄
聚合物
无机化学
作者
Takeshi Yokoyama,Shun Takaki,Keisuke Chosa,Takashi Sato,Mary Ann Suico,Yuriko Teranishi,Tsuyoshi Shuto,Mineyuki Mizuguchi,Hirofumi Kai
标识
DOI:10.1016/j.jphs.2015.09.006
摘要
Familial amyloid polyneuropathy (FAP) is a genetic, adult-onset, neurodegenerative disorder caused by amyloid formation of transthyretin (TTR), a thyroxine-binding protein. Mutation in TTR causes a propensity of TTR tetramer to dissociate to monomer, which is the first step to amyloidosis. Thus, a drug that can stabilize the tetramer structure will have therapeutic benefit. Here, by virtual screening and biochemical assays, we identified small molecule 6-benzoyl-2-hydroxy-1H-benzo[de]isoquinoline-1,3(2H)-dione (L6) that can prevent the dissociation of TTR to monomer. X-ray crystallography reveals that L6 binds to the T4 binding pocket of TTR. These findings show that L6 is a candidate TTR stabilizer.
科研通智能强力驱动
Strongly Powered by AbleSci AI